· Objective to further unlock market potential of pipeline and determine the appropriate path forward to enhance shareholder value
· Locust Walk a global life sciences transaction firm with exceptional strategic insights rooted in their deal experience
BEVERLY, MA – September 30, 2019 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to inform shareholders that the Company has engaged Locust Walk, a leading global life sciences transaction firm. Locust Walk will seek to assist the Company in maximizing the value of its assets.
“It is an exciting time at Innovation,” commented Leo Ehrlich, Chief Executive Officer at Innovation Pharmaceuticals. “Our pipeline is innovative, mature, and diversified, targeting therapeutic areas encompassing significant market opportunities—namely, in Inflammatory Bowel Disease, Dermatology, Cancer, and Infectious Disease. With our first global licensing agreement executed in July with Italy’s Alfasigma in Ulcerative Proctitis/Ulcerative Proctosigmoiditis, we continue to diligently work toward completing other transactions that would unlock additional shareholder value. As such, we are thrilled to engage Locust Walk—with their proven track record and global footprint.”
“We are very selective in deciding which companies to work with,” said Chris Ehrlich, Managing Director and Global Head of Biopharma at Locust Walk. “We look forward to working with Innovation Pharmaceuticals to help them determine the market potential and the best path forward to create value.”
Alerts
Sign-up for Innovation Pharmaceuticals email alerts is available at:
http://www.ipharminc.com/email-alerts/
About Locust Walk
Locust Walk is a leading life sciences transaction advisory firm focused on biopharmaceutical and medical technology companies. Its team of experienced professionals fuels the growth of promising companies at every stage by connecting the right products, the right partners and the most attractive sources of capital—driving innovation for growth and transformative results. Locust Walk was founded in 2009 and currently has offices in Boston; San Francisco; London; and Tokyo. For further information, including recent transactions and engagements, please visit: http://www.locustwalk.com.